Skip to content
DraconiticResearch
Search Sources API
182,549 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-NDBiology direct

Lentinan alleviates autoimmune myocarditis via inhibiting CD40 expression and GSDMD-mediated cardiomyocyte pyroptosis.

  • Xiao Huang1
  • Yongfang Huang2
  • Qi Lin3
  • Yiheng Yang4
  • Peng Yang5
  • Qingshan Tian6
6 affiliations
  1. 1Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330006, China.
  2. 2Department of Cardiology, Yingtan 184 Hospital, Yintan, Jiangxi, 335000, China.
  3. 3Department of Cardiology, Yingtan People's Hospital, Yintan, Jiangxi, 335000, China.
  4. 4The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
  5. 5Department of Cardiology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, 330006, China. [email protected].
  6. 6The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China. [email protected].
Read full textPDFDOICite

Abstract

Objective

This study aimed to investigate the molecular mechanism and regulatory effect by which lentinan (LNT) alleviates autoimmune myocarditis via suppressing CD40 expression and GSDMD-mediated cardiomyocyte pyroptosis.Methods

Fifty 8-week-old male BALB/c mice were randomly divided into 5 groups (n = 10): Control, experimental autoimmune myocarditis (EAM) model, EAM + low-dose LNT (5 mg/kg), EAM + high-dose LNT (20 mg/kg), and EAM + dexamethasone (DEX, 2.5 mg/kg). EAM was established by immunization with cardiac myosin on D0 and D7 using ‌α-MyHC. LNT and DEX were administered intraperitoneally from D8. Additionally, 40 CD40fl/flLysMCre+/- (CD40mye-KO) mice and 16 CD40WT littermates were used. CD40mye-KO mice were divided into 4 groups (n = 10): CD40mye-KO, CD40mye-KO EAM model, CD40mye-KO EAM model + High-dose LNT (20 mg/kg), CD40mye-KO EAM model + DEX (2.5 mg/kg). CD40WT mice divided into 2 groups (n = 10): CD40WT, CD40WT EAM model. The HW/BW ratio was measured, and LVEF, LVFS, LVESD, and LVEDD were assessed by echocardiography. Cardiac histopathological changes were evaluated using inflammatory scoring after H&E staining. Bone marrow-derived macrophages were pre-treated with 0.1 µg/mL LPS to induce cell damage, followed by treatment with 5 µg/mL LNT, 20 µg/mL LNT, 100 nM DEX, or 100 ng/mL CD40 activator (anti-mouse CD40 antibody fgk4.5/fgk45) for 24 h. Primary mouse cardiomyocytes were isolated from hearts, and supernatants from pyroptotic macrophages were used to treat cardiomyocytes for 24 h. Cell viability was measured using CCK-8 assay. LDH content in culture supernatant was detected to evaluate cell membrane damage. Serum and cell culture supernatants were analyzed for cTnT, CK-MB, IL-1β and IL-18 using ELISA. Protein expression of CD40, TRAF6, NF-κB p65, p-NF-κB p65, cleaved caspase-1, NLRP3, and GSDMD-N was assessed by WB. The spatial distribution of CD40 and GSDMD-N fluorescent signals and the expression of GSDMD-N in cardiomyocytes were analyzed by IF.Results

LNT significantly improved LVEF and LVFS while reducing LVESD and LVEDD in EAM mice. Both LNT doses reduced serum levels of cTnT, CK-MB, IL-1β and IL-18, with low-dose LNT exerting beneficial effects less pronounced than high-dose LNT and DEX. H&E staining demonstrated increased cardiac inflammation and immune cell infiltration in EAM mice, which was significantly alleviated by LNT and DEX treatment. WB analysis showed that LNT significantly downregulated protein expression of CD40, TRAF6, p-NF-κB p65/NF-κB p65, cleaved caspase-1, NLRP3, and GSDMD-N in myocardial tissues of EAM mice. IF staining showed that the spatial overlap and distribution of CD40 and GSDMD-N fluorescent signals was significantly reduced after LNT treatment. Reversal experiments demonstrated that LNT counteracted the effects of CD40 activator on cardiomyocyte pyroptosis. Experiments in CD40mye-KO mice confirmed that CD40 is a critical target for LNT-mediated cardiac protection. In vitro studies demonstrated that LNT regulates CD40 expression and downstream GSDMD-related pyroptosis signaling in macrophages, while a CD40 activator could partially counteract its protective effect against cardiomyocyte pyroptosis, further highlighting the central role of CD40 in LNT-regulated pyroptosis.Conclusion

Lentinan alleviates autoimmune myocarditis, and its protective effect is closely related to the inhibition of CD40 expression and the subsequent suppression of GSDMD-mediated cardiomyocyte pyroptosis.Clinical trial number

Not applicable.

Related

  1. A Self-Developed IL-6Rα Nanobody Alleviates Experimental Autoimmune Uveitis by Inhibiting Th1 and Th17 Cells
    Bochen Yao, Dali Tong, Jiaojiao Qian +7
    InflammationPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  2. Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.
    Pharmaceutical biologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCDOAJ
  3. Crocin alleviates renal fibrosis through inhibiting mitochondrial dysfunction via regulating HOXD8/PGC‑1α pathways
    Xin Li, Tian-Kui Ma, Xu Han +9
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  4. HnRNPK suppresses macrophage-driven inflammation in autoimmune myocarditis by restraining NCF1-dependent oxidized phospholipid signaling and ferroptosis-related changes.
    Han Li, Wenhu Liu, Jing Hu +10
    Redox biologyPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  5. BMI1 Overexpression Alleviates Metabolic Syndrome‐Related Liver Injury by Inhibiting the Activation of the METTL3/AHNAK Axis
    Yun‐Jiang Chen, Bei Song, Kai‐Yu Cai +2
    The Kaohsiung Journal of Medical SciencesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC

Cite

BibTeXRIS
BibTeX
@article{huang2026lentinan,
  title = {{Lentinan alleviates autoimmune myocarditis via inhibiting CD40 expression and GSDMD-mediated cardiomyocyte pyroptosis.}},
  author = {Xiao Huang and Yongfang Huang and Qi Lin and Yiheng Yang and Peng Yang and Qingshan Tian},
  journal = {Biology direct},
  year = {2026},
  month = jul,
  doi = {10.1186/s13062-026-00922-0},
  url = {https://europepmc.org/article/MED/42968098},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Lentinan alleviates autoimmune myocarditis via inhibiting CD40 expression and GSDMD-mediated cardiomyocyte pyroptosis.
AU  - Xiao Huang
AU  - Yongfang Huang
AU  - Qi Lin
AU  - Yiheng Yang
AU  - Peng Yang
AU  - Qingshan Tian
PY  - 2026
DA  - 2026/07/29
JO  - Biology direct
DO  - 10.1186/s13062-026-00922-0
UR  - https://europepmc.org/article/MED/42968098
AB  - Objective  This study aimed to investigate the molecular mechanism and regulatory effect by which lentinan (LNT) alleviates autoimmune myocarditis via suppressing CD40 expression and GSDMD-mediated cardiomyocyte pyroptosis.Methods  Fifty 8-week-old male BALB/c mice were randomly divided into 5 groups (n = 10): Control, experimental autoimmune myocarditis (EAM) model, EAM + low-dose LNT (5 mg/kg), EAM + high-dose LNT (20 mg/kg), and EAM + dexamethasone (DEX, 2.5 mg/kg). EAM was established by immunization with cardiac myosin on D0 and D7 using ‌α-MyHC. LNT and DEX were administered intraperitoneally from D8. Additionally, 40 CD40fl/flLysMCre+/- (CD40mye-KO) mice and 16 CD40WT littermates were used. CD40mye-KO mice were divided into 4 groups (n = 10): CD40mye-KO, CD40mye-KO EAM model, CD40mye-KO EAM model + High-dose LNT (20 mg/kg), CD40mye-KO EAM model + DEX (2.5 mg/kg). CD40WT mice divided into 2 groups (n = 10): CD40WT, CD40WT EAM model. The HW/BW ratio was measured, and LVEF, LVFS, LVESD, and LVEDD were assessed by echocardiography. Cardiac histopathological changes were evaluated using inflammatory scoring after H&E staining. Bone marrow-derived macrophages were pre-treated with 0.1 µg/mL LPS to induce cell damage, followed by treatment with 5 µg/mL LNT, 20 µg/mL LNT, 100 nM DEX, or 100 ng/mL CD40 activator (anti-mouse CD40 antibody fgk4.5/fgk45) for 24 h. Primary mouse cardiomyocytes were isolated from hearts, and supernatants from pyroptotic macrophages were used to treat cardiomyocytes for 24 h. Cell viability was measured using CCK-8 assay. LDH content in culture supernatant was detected to evaluate cell membrane damage. Serum and cell culture supernatants were analyzed for cTnT, CK-MB, IL-1β and IL-18 using ELISA. Protein expression of CD40, TRAF6, NF-κB p65, p-NF-κB p65, cleaved caspase-1, NLRP3, and GSDMD-N was assessed by WB. The spatial distribution of CD40 and GSDMD-N fluorescent signals and the expression of GSDMD-N in cardiomyocytes were analyzed by IF.Results  LNT significantly improved LVEF and LVFS while reducing LVESD and LVEDD in EAM mice. Both LNT doses reduced serum levels of cTnT, CK-MB, IL-1β and IL-18, with low-dose LNT exerting beneficial effects less pronounced than high-dose LNT and DEX. H&E staining demonstrated increased cardiac inflammation and immune cell infiltration in EAM mice, which was significantly alleviated by LNT and DEX treatment. WB analysis showed that LNT significantly downregulated protein expression of CD40, TRAF6, p-NF-κB p65/NF-κB p65, cleaved caspase-1, NLRP3, and GSDMD-N in myocardial tissues of EAM mice. IF staining showed that the spatial overlap and distribution of CD40 and GSDMD-N fluorescent signals was significantly reduced after LNT treatment. Reversal experiments demonstrated that LNT counteracted the effects of CD40 activator on cardiomyocyte pyroptosis. Experiments in CD40mye-KO mice confirmed that CD40 is a critical target for LNT-mediated cardiac protection. In vitro studies demonstrated that LNT regulates CD40 expression and downstream GSDMD-related pyroptosis signaling in macrophages, while a CD40 activator could partially counteract its protective effect against cardiomyocyte pyroptosis, further highlighting the central role of CD40 in LNT-regulated pyroptosis.Conclusion  Lentinan alleviates autoimmune myocarditis, and its protective effect is closely related to the inhibition of CD40 expression and the subsequent suppression of GSDMD-mediated cardiomyocyte pyroptosis.Clinical trial number  Not applicable.
SN  - 1745-6150
ER  -